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Abstract
Background: To increase the results of infertility treatment, many efforts have beenmade
to improve the treatment methods. As assisted reproductive technology is mainly using
cell culture methods, one of the approaches to improve this technology is conditioned
medium from different sources. It is desirable to apply in vitro maturation (IVM) and use
oocytes from normal cycles instead of stimulating ovulation.
Objective: To investigate the effect of human cumulus cell condition medium (hCCCM)
on the IVM of immature mouse oocytes and morphology.
Materials and Methods: In this experimental study, 240 germinal vesile oocytes were
collected from four-six wk-old mice after 48 hr of 5IU pregnant mare serum gonadotropin
(PMSG) injection and cultured in hCCCM (test group, n = 120) and DMEM + 20% FBS
(control group, n = 120). The IVM rates and changes in perivitelline space (PVS) and shape
were investigated at 8, 16, and 24 hr following the culture. The mature (MII) oocytes were
subjected to in vitro fertilization (IVF) and the fertilization rate was assessed in three days.
Results: A significant difference was observed between the maturation rates in the
hCCCM and control groups (24.16% vs 0%; p = 0.001), as well as morphologic changes
between the two groups (p = 0.04, p = 0.05). The development rate for MII oocytes
attained from IVM in the hCCCM group was 27.58% (2-cell) and 6.89% (4-cell). Data
displayed that hCCCM is an effective medium for oocytes maturation compared to the
control medium.
Conclusion: hCCCM supports oocyte in vitro growth and maturation. Moreover, hCCCM
changes the oocyte shape and size of perivitelline space.
Key words: Germinal vesicle, Cumulus cell, Conditioned medium, In vitro fertilization,
In vitro maturation, Oocyte.
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1. Introduction
An important part of reproductive medicine
in infertility treatment is ovarian stimulation by
drugs to gain a higher number of mature oocyte
retrieved for the purpose of increasing pregnancy
rates in comparison with the normal cycles (1).
Recently, drug usage has been founded to
make final oocyte maturation in patients. In
this case, one of the concerns is the oocyte
hyper stimulation syndrome (OHSS) that can
cause a significant injury in women (2). In vitro
maturation (IVM) is a desirable alternative method
which has already gained successful results in
supporting a natural in vitro fertilization (IVF)
cycle treatment with immature oocyte retrieval.
If such a technique develops further to improve
the number and quality of IVM outcomes, in
future, this might be replaced with conventional
stimulation approaches using drugs and hormones
(3).
The major advantage of applying IVM is to get
rid of the gonadotropin drugs and the risk of OHSS
in female patients (4). One of the problems in
the IVM process is providing an effective medium
that mimics in vivo conditions for the growth and
development of immature oocytes (5, 6). Oocyte
development is facilitated in the presence of
several growth factors (GFs) and specific growth
signals that are secreted by the cumulus cells
(7). Cumulus cells are considered as the oocyte
nursing cells during oogenesis which provides a
suitable microenvironment (niche) containing GFs
and other components required for oogenesis (8-
12). New studies have shown that the cumulus
cell-conditioned medium (CCCM) can meaningfully
affect the IVM and IVF rates (8, 9). Furthermore,
it has been shown that the CCCM can be
used as an in vitro niche for female gamete
development from pluripotent stem cells in buffalo
(11) and human (12). Also, a recent study has
revealed that 50% human CCCM (hCCCM) for 21
days can direct the differentiation of peritoneum
mesenchymal stem cells into the ovarian cell-like
cells and increase the expression of granulosa
cells and female germ cell genes and markers
(13).
Recently, the effect of the CCCM and granulusa
cell conditioned medium (GCCM) on mice
primordial follicles development and growth
was assessed in a new study. Their results have
indicated that CCCM and GCCM play essential
roles in oocyte maturation by secreting supporting
GFs inside the medium (10, 13, 14). Thereby, we
assumed that hCCCM may have an effective
and supportive impact in improving IVM. The
present study is the first report to investigate
whether hCCCM collected from cumulus cells in
an adherent culture (15) can improve the IVM in
mice or not. The practical goals of our study are:
Laboratory maturation optimization of immature
oocytes using conditioned environments, use
of factors in conditioned medium (CM) in the
treatment of early menopause, and prevention of
OHSS by harvesting germinal vesicle (GV) without
human chorionic gonadotropin (hCG) injection.
2. Materials and Methods
2.1. Study design and materials
In this experimental study, chemicals and
reagents were purchased from Sigma Aldrich
Co. (UK). Culture media and supplements were
purchased from Invitrogen Co. (UK), unless
otherwise stated. This study was conducted in
the Biotechnology Department of Yazd Infertility
Research and Treatment Center in 2018-2019. The
input criteria in this study were immature oocytes
of mice and the output criteria were mature (MII)
oocytes in test and control media.
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2.2. Preparation of hCCCM
The CCCM was collected from growing human
cumulus cells in the adherent monolayer culture
condition as explained elsewhere (15). After the
oocyte retrieval, cumulus cells were mechanically
separated from cumulus-oocyte complexes (COCs)
using syringe needles following enzymatic
treatment. Following washing, cumulus cells
were pelleted by centrifugation for 10 min at
500 g. Then, they were cultured with Dulbecco’s
Modified Eagle Medium + 20% Fetal bovine serum
(DMEM + 20% FBS) (Invitrogen, Gibco, UK) medium.
The medium from cultures was collected every
three days after subculture with 80% confluency.
The CCCM was filtered and stored at -20°C
(15).
2.3. Animals
Oocytes were obtained from the ovaries of 6-
8 wk-old Naval Medical Research Institute (NMRI)
female mice, while testes were obtained from 6-8
wk-old NMRI male mice. These mice were housed
and bred in the animal house at the Biotechnology
Unit of the Yazd Reproductive Sciences Institute.
The mice were kept in a 12 hr light/dark cycle, a
temperature range of 22-25°C, humidity 40-60%,
and enough nutriment.
2.4. Immature oocytes collection and
their IVM
Five IU pregnant mare serum gonadotropin
(PMSG) was injected into four-six wk-old female
mice (Figure 1A). GV oocytes from the female mice
ovaries were retrieved 48 hr after the injection by
the scratching method on the ovaries using sterile
28-gauge needles under a stereomicroscope
(Olympus, Japan; Figures 1B, 1C, and 1D). GV
oocytes (Figure 1C) were single cultured within
the separated individual microdrops of hCCCM
and DMEM + 20% FBS as the test and control
groups, respectively. The control group of this
study is similar to the control of our previously
published study (16). In total, 240 immature GV
oocytes were used in this study (n= 120/each).
Next, they were placed in an incubator (37°C
temperature, 5% CO2). Oocyte maturation,
shape, and perivitelline space (PVS) changes
were evaluated once every eight hours by a
stereomicroscope. Oocytes with a polar body
were considered as MII oocytes and were selected
for the IVF procedure.
2.5. IVF and embryo development
The developmental potential rate of MII
oocytes was evaluated by IVF. Male mice
spermatozoa cells were obtained from the
caudal epididymis and capacitated for 1 hr at
37°C. MII oocytes were incubated with sperms
in the GIVF medium (Vitrolife, Sweden) for 4 hr.
After washing the oocytes for removal of extra
sperms, they were cultured in a G1-plus micro-drop
(Vitrolife, Sweden) and placed in an incubator
(37°C temperature, 5% CO2), for three days. The
embryo development rate was evaluated at 24,
48, and 72 hr after the insemination using a
stereomicroscope.
2.6. Ethical consideration
The research proposal was approved by Shahid
Sadoughi University of Medical Sciences ethics
committee (code: IR.SSU. REC.1397.087). In this
study, cumulus cells were obtained from the
male-factor infertile couples participated in our
previous study (15) according to the approval of the
ethics committee. All ethical protocols for working
with laboratory animals were observed in this
study.
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2.7. Statistical analysis
Changes in oocytes’ shape and PVS, maturation
rate and embryo development rate in mice oocytes
were assessed at each step and compared
between the two groups. Statistical analysis was
done using the Chi-square test with an R.V.16
software. P ≤ 0.05. was considered as statistically
significant.
3. Results
3.1. Effect of hCCCM on IVM
Resumption of meiosis to the MII stage or IVM
of immature GV oocytes (Figures 1E and 1I) was
evaluated after 8 hr (Figures 1F and 1J), 16 hr
(Figures 1G and 1K), and 24 hr (Figures 1H and 1L)
following the oocyte pick-up and culture in the test
(hCCCM) and control (DMEM + 20% FBS) groups.
Significant difference was seen in the IVM rates
between the hCCCM and control medium at 16 and
24 hr (p = 0.001, Table I). Table I shows the number
and percentage of degenerated, meiosis I stage
(MI), and MII oocytes in the test and control groups
at different times. Some of the immature oocytes
were developed to the MI stage after 8 hr in both
media. While the rate of the degenerated oocytes
at 8 hr in the hCCCM medium was less than the
control medium (Table I), the rate of MI oocytes in
the hCCCM group was significantly higher than the
control group (p = 0.01; Table I). The percentage of
the MII oocytes in the hCCCM medium at 8 hr was
similar to the control medium (Table I).
IVM rate was checked in both groups after 16
hr and as a result, the degenerated oocytes in the
hCCCMgroupwere less than degenerated oocytes
in the control group (Table I). A percentage of MI
and MII oocytes in hCCCM was higher than the
control group (Table I). The degenerated oocytes
after 24 hr in the hCCCM were less than the
degenerated oocytes in the control group (Table I).
Half of the oocytes developed to the MI stage in
hCCCM after 24 hr (Table I) and about one-fourth
of them reached to the MII stage (Table I); however,
in the control group, only 9 of the 120 oocytes
developed further to theMI stage and none of them
developed to the MII (Table I).
Overall, data showed that the degeneration rate
in both groups increased after 24 hr, and although
this ratio was slightly lower than the control group,
the difference was not significant (p = 0.46; Table I).
In both media, the immature GV oocytes supported
the MI stage which this progress was higher in the
hCCCMmedium (Table I). The MI stage decreasing
trend in the hCCCM medium during 24 hr might be
because of the growth of the oocytes to the MII
stage (Table I). Also, in the control medium, the MI
rate decreased after 24 hr which was either due
to the degeneration or arrest after 16 hr (Table I).
The MII rate increase in the test group after 24
hr shows the positive effect of the time on oocyte
growth in the hCCCM group. In the control medium,
at 24 hr, despite the growth of the oocytesMI stage,
none of them reach to the MII stage (Table I). Our
results show that there are factors secreted from
human cumulus cells (hCCs) that support IVM in
mice.
3.2. Morphology evaluation of oocytes
Morphological assessment is one of the
important and basic tools for evaluating the
quality of oocytes (16, 17). In this study, large PVS
and irregular shape of oocytes were checked as
the morphological criteria. Figure 2A-2F show
examples of normal and abnormal oocytes in
terms of shape and PVS. The rates of large PVS
oocytes and rates of irregular-shape oocytes
at 8, 16, and 24 hr in the hCCCM medium
and control group were shown in the table
II. The results of this study show that there
Page 1022 https://doi.org/10.18502/ijrm.v18i12.8023
International Journal of Reproductive BioMedicine Human CCCM for IVM of mouse oocytes
are significant differences in the rate of large
PVS (p = 0.05) and irregular-shaped (p = 0.04)
between the hCCCM and control groups (Table
II).
3.3. Embryo development rate
following IVF
MII oocytes were inseminated for the IVF
procedure to evaluate their fertilization capacity
after IVM. Following IVF, embryo development
was checked for three days. None of the
embryos were developed further than four
cells in the cleavage stage (Figures 3A and
3B). The percentage of two-cell and four-cell
embryos after 24, 48, and 72 hr were shown
in the Figure 3C. The developmental rate of
embryos to two-cell stage increased until the
second day post IVF, then stopped on the third
day (Figure 3C), and the formation of the four-cell
embryos began from the third day post IVF (Figure
3C).
Table I. IVM rates at 8, 16, and 24 hr in the hCCCM and DMEM + 20% FBS groups
Deg. MI MIIGroup
8 hr 16 hr 24 hr 8 hr 16 hr 24 hr 8 hr 16 hr 24 hr
hCCCM 21 (17.5) 28 (23.33) 31 (25.83) 87 (72.5) 69 (57.5) 60 (50) 0 (0) 23 (19.16) 29 (24.16)
DMEM + 20%FBS 29 (24.17) 40 (33.33) 63 (52.5) 11 (9.17) 9 (7.5) 9 (7.5) 0 (0) 0 (0) 0 (0)
P-value 0.46 * 0.01 *0.001
Data presented as n (%) in different times. Chi-square test; *Significant level of≤ 0.05, hCCCM: Human cumulus cell-conditioned
medium; DMEM + 20%FBS: Dulbecco’s modified eagle’s medium + 20% fetal bovine serum; Deg.: Degenerated; MI: Meiosis I;
MII: Meiosis II
Table II. Rate of oocytes large/normal PVS and irregular/normal shape following IVM in hCCCM and control group at different
times
hCCCM DMEM + 20% FBSGroup
8 hr 16 hr 24 hr 8 hr 16 hr 24 hr
P-value
Large PVS 41 (34.16) 47 (39.16) 57 (47.5) 10 (8.33) 29 (24.16) 35 (29.16) * 0.05
Irregular shape 19 (15.83) 28 (23.33) 38 (31.66) 8 (6.66) 31 (25.83) 51 (42.5) * 0.04
Data presented as n (%) in different times. Chi-square test; *Significant level of≤ 0.05, hCCCM: Human cumulus cell-conditioned
medium; DMEM + 20% FBS: Dulbecco’s modified eagle’s medium + 20% fetal bovine serum; PVS: Perivitelline space
Figure 1. GV oocytes retrieval process in mice and IVM. First, an injection of 5IU PMSG was given to four-six week-old mouse (A).
Ovaries were taken from stimulated mice and using the stereo microscope ovary was scratched (B). Each immature GV oocyte (C)
was recovered and then cultured separately and individually in 10-μl micro drops (D). IVM progress stages at different times in the
hCCCM and control groups. After 16 and 24 hr in the hCCCM medium, some of the GV oocytes (E) developed and became MI (F)
and mature MII oocytes (G, H). Nevertheless, in the DMEM + 20% FBS medium, GV oocytes (I) could develop to MI oocytes ( J-L)
but none of them could complete the IVM process to form MII oocytes.
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Figure 2. The PVS and shape change rate of oocytes in the hCCCM and control media during the IVM process. (A) Normal GV.
(B) Normal MI. (C) Normal MII. (D) Large PVS. (E and F) Irregular shape and large PVS.
Figure 3. Embryo development following IVF of MII oocytes from the hCCCM group. Following IVF from 29 oocytes, after 24 hr, six
of the fertilized oocytes developed to two-cell embryos (A and C) and none of them reached four cells. After 48 hr, eight embryos
developed to two cells (A and C) and none of them reached four-cells embryos. At 72 hr following IVF, eight embryos arrested at
two-cell stage and instead two embryos were observed at four-cell stage (B and C). The embryos did not follow further but after
three days none of them formed blastocyst.
4. Discussion
This study assessed the effect of the hCCCM on
the IVM rates of the GV oocytes inmice. The data of
this study show that hCCCMsupports IVMofmouse
GV oocytes compared to the DMEM + 20% FBS
as the control group (24.16% vs 0%). Additionally,
the MII oocytes achieved by IVM in the hCCCM
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medium were fertilized in vitro (IVF) from which
6.89% developed to the four-cell stage. Usually,
70-85% of oocytes from stimulated cycles are MII
stage, with the remainder variably at GV or MI
stage (17) .In some women, many immature oocytes
(> 30%) can be produced despite the use of
contemporary stimulation for clinical IVF. In such
people, the fertilization, and embryo development
rates are usually low (18, 19).
Thus, many researches were led based on the
choice of proper factors to adapt the culture
condition to progress the oocyte IVM efficacy
in mouse, bovine, and human (20-22). It was
shown that with the addition of some GFs, for
example, Epidermal Growth Factors (EGFs) or
insulin Growth Factors (IGFs), to the IVM medium,
the rate of maturity and embryo development can
be improved considerably (23, 24). The supportive
effect of the EGF was shown in several species
such as canine (25), mouse (26), and humans (27).
Also, it was revealed that growth differentiation
factor 9 (GDF9) supports the folliculogenesis in
bovine (28), mice (29), and human (30). Additionally,
CM is a vital culture complement device in the IVM
method (28, 31). Similar to our study, cross-species
experiments have shown the CM positive effects of
one species in the IVM of another species’ oocytes
(28, 31). For example, the IVM of canine oocytes
in bovine COC-CM (9) or canine oocyte IVM in the
CM of mouse embryonic fibroblasts (32), IVM of
mouse oocytes in the CM of human bone marrow
mesenchymal stem cell (33), and mouse oocyte
IVM in the CM of the human testicular cell (16). It
was shown that the CM of granulosa cells facilitate
IVM as confirmed by the MII oocytes formation and
gene expression profile assessment (31).
Our data confirms the previously reported data
as hCCCM supports the IVM in mice oocytes.
Interestingly, the data reveals that factors secreted
by CCs during the first eight hours of maturation are
vital for oocyte development. Our data supports the
previous report which indicated that the first eight
hours of maturation is vital for the achievement
of oocyte growth during the remaining 15 hr
of maturation (8). Using metabolomics profile, it
was shown that the IVM of denuded oocytes
in COC-CM resulted in a better outcome than
the IVM of denuded oocytes that completed
maturation in standard IVM medium. Cumulus
cells are necessary for the growth of oocytes
during maturation and are supposed to secrete
several factors that improve the growth ability of
denuded oocytes (8). In another study, the short-
term exposure of COCs to the IVM medium prior
to ICSI indicated the improvement of the rate of
theMII oocyte and embryo development (34). Thus,
CCCM has the elements that play a critical role in
oocyte maturation, which can be used to develop
a new condition to improve IVM results.
The GV retrieval techniques and the IVM basal
medium are additional topics that may have an
influence on the result of IVM (35). Here, we
have used the scratching method for oocyte
retrieval and DMEM + 20% FBS was used as a
basal medium for both the control and test groups
to keep the condition as consistent as possible
during the study. The other issue which was
investigated in the current study was the effect of
the medium (test and control) on the morphology
of the oocytes following culture. Some data
have shown that oocyte morphology plays a
significant role in their subsequent fertilization
and cleavage rates and on the embryo quality
(36, 37). Moreover, IVM of oocytes without
anomalies produces higher-quality embryos
than eggs with anomalies (36). Irregularities of
PVS are among the most important anomalies
of the extra cytoplasmic cause. It has been
studied that a large PVS might be associated
with increased degeneration of oocytes (36)
and lower fertilization rates (37). In the current
study, hCCCM caused the formation of large PVS
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in IVM oocytes, whereas the irregular shape of
the oocytes was observed more in the control
group. The reasons for these differences are
unknown but might be due to the osmolality of
the different IVM cultures and factors within the
hCCCM.
5. Conclusion
In conclusion, for the first time, our data indicated
that hCCCM from cultures of adherent cumulus
cells can support IVM of mouse GV oocytes.
The IVF/IVC of the MII oocytes was assessed for
three days to the formation of two- and four-
cells embryos. Moreover, the hCCCM caused the
formation of large PVS, however, the shape of
oocytes becamemore irregular in the DMEM + 20%
FBS.
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